Junji Furuse
Impact in
- Hepatology top 0.1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 0.2%
- Pancreatic and Hepatic Oncology Research
Papers in
- Co-authors
- Takuji Okusaka (150 shared papers)Hiroshi Ishii (85 shared papers)Masafumi Ikeda (144 shared papers)Christos N. Papandreou (8 shared papers)Laura Ladrón de Guevara (7 shared papers)Alan P. Venook (5 shared papers)Chigusa Morizane (69 shared papers)Masatoshi Kudo (49 shared papers)
- Journals
- Journal of Clinical Oncology (94 papers)Annals of Oncology (43 papers)Japanese Journal of Clinical Oncology (36 papers)Cancer Science (14 papers)Cancer Chemotherapy and Pharmacology (14 papers)
- Partner nations
- JapanUnited StatesSouth Korea
In The Last Decade
Junji Furuse
399 papers receiving 12.9k citations
Junji Furuse's Hit Papers
Peers
Comparison fields: 5 of 126
- Hepatology 3.6k
- Oncology 5.2k
- Cancer Research 1.6k
- Surgery 3.6k
- Pulmonary and Respiratory Medicine 2.2k
Countries citing papers authored by Junji Furuse
This map shows the geographic impact of Junji Furuse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junji Furuse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junji Furuse more than expected).
Fields of papers citing papers by Junji Furuse
This network shows the impact of papers produced by Junji Furuse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junji Furuse. The network helps show where Junji Furuse may publish in the future.
Co-authors
The 25 scholars most cited alongside Junji Furuse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 426 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Incidence and Epidemiology of Hepatocellular Carcinoma: A Global and Regional Perspective Hit paper breakdown → | 2010 | 807 |
| 2 | Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan Hit paper breakdown → | 2010 | 557 |
| 3 | Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib Hit paper breakdown → | 2014 | 460 |
| 4 | Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05) Hit paper breakdown → | 2018 | 390 |
| 5 | 2011 | 333 | |
| 6 | 2020 | 287 | |
| 7 | 2013 | 278 | |
| 8 | Phase 3 randomized, open-label, multicenter study of tremelimumab (T) and durvalumab (D) as first-line therapy in patients (pts) with unresectable hepatocellular carcinoma (uHCC): HIMALAYA. Hit paper breakdown → | 2022 | 272 |
| 9 | 2016 | 272 | |
| 10 | 2012 | 260 | |
| 11 | Nivolumab alone or in combination with cisplatin plus gemcitabine in Japanese patients with unresectable or recurrent biliary tract cancer: a non-randomised, multicentre, open-label, phase 1 study Hit paper breakdown → | 2019 | 252 |
| 12 | 2017 | 213 | |
| 13 | 2013 | 184 | |
| 14 | 2014 | 180 | |
| 15 | 2008 | 170 | |
| 16 | 2007 | 162 | |
| 17 | 2005 | 161 | |
| 18 | 2006 | 158 | |
| 19 | 2007 | 141 | |
| 20 | 2014 | 134 |
About Junji Furuse
Junji Furuse is a scholar working on Oncology, Surgery, Hepatology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 426 papers that have together received 13.2k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (140 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (117 papers), Hepatocellular Carcinoma Treatment and Prognosis (104 papers), Cancer Genomics and Diagnostics (50 papers), Gallbladder and Bile Duct Disorders (31 papers), Colorectal Cancer Treatments and Studies (28 papers), Neuroendocrine Tumor Research Advances (28 papers) and Cancer Mechanisms and Therapy (19 papers). The work is most often cited by research in Hepatology (3.6k citations), Oncology (5.2k citations), Cancer Research (1.6k citations), Surgery (3.6k citations) and Pulmonary and Respiratory Medicine (2.2k citations). Junji Furuse has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Takuji Okusaka, Hiroshi Ishii, Masafumi Ikeda, Christos N. Papandreou, Laura Ladrón de Guevara, Alan P. Venook, Chigusa Morizane, Masatoshi Kudo, Makoto Ueno and Kohei Nakachi. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Japanese Journal of Clinical Oncology, Cancer Science and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.